Related Experiment Video
Updated: Jul 29, 2025

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
M1 macrophage-derived exosomes containing miR-150 inhibit glioma progression by targeting MMP16
Pengfei Yan1, Jia Wang2, Hongya Liu3
1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei 430022, China.
Abstract:
A large amount of clinical and experimental evidence indicates that M1 macrophages can inhibit tumor progression and expansion; however, the molecular mechanism by which macrophage-derived exosomes inhibit the proliferation of glioblastoma cells has not yet been elucidated. Here, we used M1 macrophage exosomes encapsulating microRNAs to inhibit the proliferation of glioma cells. Exosomes derived from M1 macrophages exhibited high expression levels of miR-150, and the inhibition of glioma cell proliferation mediated by exosomes derived from M1 macrophages was dependent on this microRNA. Mechanistically, miR-150 is transferred to glioblastoma cells through M1 macrophages and binds to MMP16, downregulating its expression and inhibiting glioma progression. Overall, these findings indicate that M1 macrophage-derived exosomes carrying miR-150 inhibit the proliferation of glioblastoma cells through targeted binding to MMP16. This dynamic mutual influence between glioblastoma cells and M1 macrophages provides new opportunities for the treatment of glioma.
Insights
M1 macrophage exosomes carrying miR-150 inhibit glioblastoma cell growth. This microRNA targets MMP16, offering a novel therapeutic strategy for glioma treatment.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- M1 macrophages show anti-tumor properties, but their exosome-mediated mechanisms against glioblastoma are unclear.
- Glioblastoma multiforme is an aggressive brain tumor with limited treatment options.
Purpose of the Study:
- To investigate the role of M1 macrophage-derived exosomes in inhibiting glioblastoma cell proliferation.
- To elucidate the molecular mechanism underlying this inhibition.
Main Methods:
- Isolation and characterization of exosomes from M1 macrophages.
- Treatment of glioblastoma cells with M1 macrophage exosomes.
- Quantification of microRNA (miR-150) levels and its target (MMP16) expression.
- Assessment of glioblastoma cell proliferation.
Main Results:
- M1 macrophage exosomes significantly inhibited glioblastoma cell proliferation.
- Exosomes were enriched with miR-150, which was crucial for the anti-proliferative effect.
- miR-150 directly targeted and downregulated Matrix Metallopeptidase 16 (MMP16) in glioblastoma cells.
Conclusions:
- M1 macrophage-derived exosomes carrying miR-150 inhibit glioblastoma progression by downregulating MMP16.
- This exosome-mediated pathway presents a promising avenue for novel glioma therapeutics.
Related Concept Videos
The Tumor Microenvironment
MicroRNAs
Mesenchymal Stem Cells

